Merit Medical Systems (MMSI) Non-Current Deffered Revenue (2010 - 2026)
Merit Medical Systems (MMSI) posted Non-Current Deffered Revenue of $19.3 million for Q2 2026, up 11.07% sequentially from $17.4 million in Q1 2026, and down 2.54% YoY from $19.8 million in Q2 2025.
Merit Medical Systems (MMSI) Non-Current Deffered Revenue (2010 - 2026) Analysis & Trends
Merit Medical Systems has reported Non-Current Deffered Revenue for 17 years, with the latest figure at $19.3 million in Q2 2026.
- Quarterly Non-Current Deffered Revenue fell 2.54% year-over-year to $19.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $19.3 million (down 2.54% YoY) and the FY2025 annual result came in at $17.5 million, down 8.64% from the prior year.
- Non-Current Deffered Revenue advanced to $19.3 million in Q2 2026 per MMSI's latest filing, from $17.4 million in the prior quarter.
- Over five years, Non-Current Deffered Revenue peaked at $19.8 million in Q2 2025 and troughed at $14.8 million in Q3 2022.
- A 5-year average of $17.4 million and a median of $17.3 million in 2023 frame the typical range for Non-Current Deffered Revenue.
- The sharpest annual moves came in 2022 and 2024: Non-Current Deffered Revenue decreased 15.52% in 2022, then advanced 23.92% in 2024.
- Over 5 years, Non-Current Deffered Revenue stood at $15.3 million in 2022, then gained by 12.42% to $17.2 million in 2023, then rose by 11.63% to $19.2 million in 2024, then fell by 8.64% to $17.5 million in 2025, then grew by 10.0% to $19.3 million in 2026.
- According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $19.3 million, $17.4 million, and $17.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 170.95 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 13.90 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 208.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Merit Medical Systems | 5.43 Bn | 4.98 Bn | 215.17 Mn | 19.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.30 Mn |
| Mar 31, 2026 | 17.37 Mn |
| Dec 31, 2025 | 1.40 Mn |
| Sep 30, 2025 | 1.42 Mn |
| Jun 30, 2025 | 1.45 Mn |
| Mar 31, 2025 | 18.62 Mn |
| Dec 31, 2024 | 1.50 Mn |
| Sep 30, 2024 | 1.53 Mn |
| Jun 30, 2024 | 18.59 Mn |
| Mar 31, 2024 | 18.23 Mn |
| Dec 31, 2023 | 1.61 Mn |
| Sep 30, 2023 | 15.51 Mn |
| Jun 30, 2023 | 16.42 Mn |
| Mar 31, 2023 | 15.87 Mn |
| Dec 31, 2022 | 15.30 Mn |
| Sep 30, 2022 | 1.74 Mn |
| Jun 30, 2022 | 1.76 Mn |
| Mar 31, 2022 | 16.80 Mn |
| Dec 31, 2021 | 1.82 Mn |
| Sep 30, 2021 | 17.41 Mn |